FLCCC | Front Line COVID-19 Critical Care Alliance
FLCCC | Front Line COVID-19 Critical Care Alliance
Donate
FLCCC in the News

Dr. Kory on Ivermectin vs. Merck’s New Drug

Published On: October 2, 2021|
Print Friendly, PDF & Email

FLCCC founder and Chief Medical Officer, Dr. Pierre Kory, talked to The Balance and compared Merck’s “COVID pill” and ivermectin.

Explore Similar Stories

Title

Go to Top